DURHAM, N.C., Nov. 16, 2023 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Thomas Riga as Chief Operating and Commercial Officer. “We are excited to welcome Tom…Read More
Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief
